The engineered antitumor bacteria can also serve as delivery carriers, enabling precise release of therapeutic drugs and opening up a new pathway for the treatment of malignant tumors, he added.

Going forward, Delconte’s team hopes to achieve enhanced antitumor immunity by targeting the pathways activated by fasting, without requiring the patients to fast. “If we can target those pathways ...

BeiGene has made the decision to end the clinical development program for ociperlimab (BGB-A1217) for the treatment of non-small cell lung cancer ...

Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at Beijing Friendship Hospital, Capital Medical University, published a review ...

Our laboratory is dedicated to understanding the consequences of activation of these pathways and to using this information to develop mechanism ... inhibition of upstream receptors increases their ...

Findings from a phase 1 trial demonstrate that silmitasertib shows potential for the treatment of patients with advanced ...

Basophils trigger a cytokine cascade that improves antitumor immunity in mice, offering potential targets for cancer immunotherapy ... Their analysis pointed to IL-4 signaling as a key pathway ...

A recent study published in ACS Nano explored a novel strategy to reprogram the liver’s immune environment and generate an antitumor response ... genes (STING) pathway. This dual approach ...

The work entitled “ Semen podocarpi extract enhances radiosensitivity in nasopharyngeal carcinoma cells via Raf/MEK/ERK ...